| 000 | 01540 a2200493 4500 | ||
|---|---|---|---|
| 005 | 20250515111608.0 | ||
| 264 | 0 | _c20080324 | |
| 008 | 200803s 0 0 eng d | ||
| 022 | _a1472-4146 | ||
| 024 | 7 |
_a10.1136/jcp.2007.049692 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aKhan, S | |
| 245 | 0 | 0 |
_aThe clinical significance of antinucleolar antibodies. _h[electronic resource] |
| 260 |
_bJournal of clinical pathology _cMar 2008 |
||
| 300 |
_a283-6 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article | ||
| 650 | 0 | 4 | _aAged |
| 650 | 0 | 4 | _aAged, 80 and over |
| 650 | 0 | 4 |
_aAntibodies, Antinuclear _xblood |
| 650 | 0 | 4 |
_aAutoimmune Diseases _xblood |
| 650 | 0 | 4 |
_aBiomarkers _xblood |
| 650 | 0 | 4 | _aCell Line |
| 650 | 0 | 4 |
_aConnective Tissue Diseases _xblood |
| 650 | 0 | 4 | _aEnzyme-Linked Immunosorbent Assay |
| 650 | 0 | 4 | _aFemale |
| 650 | 0 | 4 | _aFluorescent Antibody Technique, Indirect |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 | _aImmunoblotting |
| 650 | 0 | 4 |
_aImmunoglobulin G _ximmunology |
| 650 | 0 | 4 | _aMale |
| 650 | 0 | 4 | _aMiddle Aged |
| 650 | 0 | 4 |
_aNeoplasms _ximmunology |
| 650 | 0 | 4 | _aPredictive Value of Tests |
| 650 | 0 | 4 | _aPrevalence |
| 650 | 0 | 4 |
_aScleroderma, Systemic _ximmunology |
| 700 | 1 | _aAlvi, A | |
| 700 | 1 | _aHolding, S | |
| 700 | 1 | _aKemp, M L | |
| 700 | 1 | _aRaine, D | |
| 700 | 1 | _aDoré, P C | |
| 700 | 1 | _aSewell, W A C | |
| 773 | 0 |
_tJournal of clinical pathology _gvol. 61 _gno. 3 _gp. 283-6 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1136/jcp.2007.049692 _zAvailable from publisher's website |
| 999 |
_c17808530 _d17808530 |
||